ArticleOncology letters2021

LACTB and LC3 could serve as potential biomarkers of gastric cancer to neoadjuvant chemotherapy with oxaliplatin plus S-1.

Fang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.